Cell Signaling Pathways in Cancer at CIOC 2027

Cell signaling pathways in cancer are crucial mechanisms that regulate cellular behavior, including growth, survival, and differentiation. In cancer, these pathways often become dysregulated, leading to uncontrolled cell division and tumor formation. Key pathways involved in cancer include the PI3K/Akt, MAPK/ERK, and Wnt/β-catenin pathways, which are responsible for transmitting signals from the cell surface to the nucleus. When these pathways are mutated or overactive, they can promote cancer cell proliferation, resistance to cell death, and metastasis. Targeting these signaling pathways is a major focus of cancer therapy, as drugs that block specific components of these pathways can potentially halt cancer progression. However, because these pathways are interconnected and often redundant, designing effective treatments requires a deep understanding of their complexities. Research continues to explore how targeting multiple pathways simultaneously or identifying new therapeutic targets within these pathways can provide more effective and durable treatment options for cancer patients.